Spread awareness by sharing and learning more. Post the social media graphic, sign up for a conference, March for Marrow, and AAMDSIF Global PNH Patient Registry! Learn more about PNH.
Paroxysmal Nocturnal Hemoglobinuria (PNH) Donate to Support Our Mission
Dr. Virian Serei discusses how bone marrow failure is diagnosed, including the tests and evaluations used to receive a diagnosis of of aplastic anemia, myelodysplastic syndromes (MDS), or paroxysmal nocturnal hemoglobinuria (PNH).
Dr. Srinivasa Samikommu discusses bone marrow transplant, the transplant process, how doctors determine if it may be right for a patient and what you as a patient need to consider before moving forward with a transplant. The session was recorded at the 2026 AAMDSIF New Brunswick…
Drs. Xiaoyi Chen and Payal Sojitra discuss diagnosis approaches, key differences and treatment considerations for Lower-Risk MDS, Higher-Risk MDS, and MDS/MPN Overlap. The session was recorded live at the 2026 AAMDSIF New Brunswick Patient and Family Conference.
CONFERENCE AGENDA - November 7, 2026
8:00 - 2:45 (Central Time Zone)
AAMDSIF is pleased to announce that we will host a support group exclusively for Health Care Professionals diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_
Relapse remains the main cause of death following allogeneic hematopoietic cell transplantation (HCT) for patients with high-risk myeloid malignancies. Post-transplant maintenance therapy may reduce relapse risk and improve outcomes. We previously showed that post-transplant azacitidine
Baseline IPSS-M risk, response to hypomethylating agent (HMA) therapy, and receipt of allogeneic stem cell transplant
The World Health Organization and international consensus 2022 classifications have proposed lowering the absolute monocyte monocyte:
Approximately half of patients with myelodysplastic syndromes myelodysplastic syndromes:
